Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFEPEDRUG desmopressin oral lyophilisate pediatric PK/PD study
2014-005200-13Phase 4Completed
- Sponsor
- Ghent University
- Start
- Jun 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of desmopressin in nocturnal enuresis (NE) and Uronephropathy, sponsored by Ghent University. Primary endpoint: Influence of anthropometric factors on desmopressin pharmacokinetics. Started Jun 2015; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)Uronephropathy
Beyond the preview
Go deeper on 2014-005200-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005200-13.